- call +1-201-465-4211
- email sales@mrinsights.biz
Hospital acquired urinary tract infections are caused by patients urethral catheters or invasive manipulation in the urogenital tract, which allows microbes to enter into the bladder and encourages proliferation by providing a sustainable environment.
Scope of the Report:
They are accountable for over 50% of infections.
An array of tests can uncover type of infection and pathogen associated with the infection to efficiently treat the infected area.
Increase in prevalence of hospital acquired UTIs and technological advancement in testing devices drive the market.
The worldwide market for Hospital Acquired Urinary Tract Infection is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Hospital Acquired Urinary Tract Infection in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Advanced Sterilization Products
Becton
Dickinson and Company
Steris Corporation
Getinge Group
Kimberly-Clark Corporation
Cantel Medical
Biomerieux
Belimed
3M Company
Sterigenics International
Synergy Health
PLC
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Microbial Testing Instruments
Reagents and Consumables
Infection Prevention and Surveillance Software
Market Segment by Applications, can be divided into
Disease Testing
Drug-resistance Testing
There are 15 Chapters to deeply display the global Hospital Acquired Urinary Tract Infection market.
Chapter 1, to describe Hospital Acquired Urinary Tract Infection Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hospital Acquired Urinary Tract Infection, with sales, revenue, and price of Hospital Acquired Urinary Tract Infection, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hospital Acquired Urinary Tract Infection, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hospital Acquired Urinary Tract Infection market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hospital Acquired Urinary Tract Infection sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Hospital Acquired Urinary Tract Infection Introduction
1.2 Market Analysis by Type
1.2.1 Microbial Testing Instruments
1.2.2 Reagents and Consumables
1.2.3 Infection Prevention and Surveillance Software
1.3 Market Analysis by Applications
1.3.1 Disease Testing
1.3.2 Drug-resistance Testing
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Advanced Sterilization Products
2.1.1 Business Overview
2.1.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Becton
2.2.1 Business Overview
2.2.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dickinson and Company
2.3.1 Business Overview
2.3.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Dickinson and Company Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Steris Corporation
2.4.1 Business Overview
2.4.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Steris Corporation Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Getinge Group
2.5.1 Business Overview
2.5.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Getinge Group Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kimberly-Clark Corporation
2.6.1 Business Overview
2.6.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cantel Medical
2.7.1 Business Overview
2.7.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cantel Medical Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biomerieux
2.8.1 Business Overview
2.8.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biomerieux Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Belimed
2.9.1 Business Overview
2.9.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Belimed Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 3M Company
2.10.1 Business Overview
2.10.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 3M Company Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sterigenics International
2.11.1 Business Overview
2.11.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sterigenics International Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Synergy Health
2.12.1 Business Overview
2.12.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Synergy Health Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 PLC
2.13.1 Business Overview
2.13.2 Hospital Acquired Urinary Tract Infection Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 PLC Hospital Acquired Urinary Tract Infection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hospital Acquired Urinary Tract Infection Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Hospital Acquired Urinary Tract Infection Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hospital Acquired Urinary Tract Infection Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Hospital Acquired Urinary Tract Infection Manufacturer Market Share in 2017
3.3.2 Top 6 Hospital Acquired Urinary Tract Infection Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Hospital Acquired Urinary Tract Infection Market Analysis by Regions
4.1 Global Hospital Acquired Urinary Tract Infection Sales, Revenue and Market Share by Regions
4.1.1 Global Hospital Acquired Urinary Tract Infection Sales and Market Share by Regions (2013-2018)
4.1.2 Global Hospital Acquired Urinary Tract Infection Revenue and Market Share by Regions (2013-2018)
4.2 North America Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
4.3 Europe Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
4.5 South America Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
5 North America Hospital Acquired Urinary Tract Infection by Countries
5.1 North America Hospital Acquired Urinary Tract Infection Sales, Revenue and Market Share by Countries
5.1.1 North America Hospital Acquired Urinary Tract Infection Sales and Market Share by Countries (2013-2018)
5.1.2 North America Hospital Acquired Urinary Tract Infection Revenue and Market Share by Countries (2013-2018)
5.2 United States Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
5.3 Canada Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
5.4 Mexico Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
6 Europe Hospital Acquired Urinary Tract Infection by Countries
6.1 Europe Hospital Acquired Urinary Tract Infection Sales, Revenue and Market Share by Countries
6.1.1 Europe Hospital Acquired Urinary Tract Infection Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Hospital Acquired Urinary Tract Infection Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
6.3 UK Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
6.4 France Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
6.5 Russia Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
6.6 Italy Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
7 Asia-Pacific Hospital Acquired Urinary Tract Infection by Countries
7.1 Asia-Pacific Hospital Acquired Urinary Tract Infection Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hospital Acquired Urinary Tract Infection Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue and Market Share by Countries (2013-2018)
7.2 China Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
7.3 Japan Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
7.4 Korea Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
7.5 India Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
8 South America Hospital Acquired Urinary Tract Infection by Countries
8.1 South America Hospital Acquired Urinary Tract Infection Sales, Revenue and Market Share by Countries
8.1.1 South America Hospital Acquired Urinary Tract Infection Sales and Market Share by Countries (2013-2018)
8.1.2 South America Hospital Acquired Urinary Tract Infection Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
8.3 Argentina Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
8.4 Colombia Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
9 Middle East and Africa Hospital Acquired Urinary Tract Infection by Countries
9.1 Middle East and Africa Hospital Acquired Urinary Tract Infection Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hospital Acquired Urinary Tract Infection Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Hospital Acquired Urinary Tract Infection Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
9.3 UAE Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
9.4 Egypt Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
9.5 Nigeria Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
9.6 South Africa Hospital Acquired Urinary Tract Infection Sales and Growth Rate (2013-2018)
10 Global Hospital Acquired Urinary Tract Infection Market Segment by Type
10.1 Global Hospital Acquired Urinary Tract Infection Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hospital Acquired Urinary Tract Infection Sales and Market Share by Type (2013-2018)
10.1.2 Global Hospital Acquired Urinary Tract Infection Revenue and Market Share by Type (2013-2018)
10.2 Microbial Testing Instruments Sales Growth and Price
10.2.1 Global Microbial Testing Instruments Sales Growth (2013-2018)
10.2.2 Global Microbial Testing Instruments Price (2013-2018)
10.3 Reagents and Consumables Sales Growth and Price
10.3.1 Global Reagents and Consumables Sales Growth (2013-2018)
10.3.2 Global Reagents and Consumables Price (2013-2018)
10.4 Infection Prevention and Surveillance Software Sales Growth and Price
10.4.1 Global Infection Prevention and Surveillance Software Sales Growth (2013-2018)
10.4.2 Global Infection Prevention and Surveillance Software Price (2013-2018)
11 Global Hospital Acquired Urinary Tract Infection Market Segment by Application
11.1 Global Hospital Acquired Urinary Tract Infection Sales Market Share by Application (2013-2018)
11.2 Disease Testing Sales Growth (2013-2018)
11.3 Drug-resistance Testing Sales Growth (2013-2018)
12 Hospital Acquired Urinary Tract Infection Market Forecast (2018-2023)
12.1 Global Hospital Acquired Urinary Tract Infection Sales, Revenue and Growth Rate (2018-2023)
12.2 Hospital Acquired Urinary Tract Infection Market Forecast by Regions (2018-2023)
12.2.1 North America Hospital Acquired Urinary Tract Infection Market Forecast (2018-2023)
12.2.2 Europe Hospital Acquired Urinary Tract Infection Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Forecast (2018-2023)
12.2.4 South America Hospital Acquired Urinary Tract Infection Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Forecast (2018-2023)
12.3 Hospital Acquired Urinary Tract Infection Market Forecast by Type (2018-2023)
12.3.1 Global Hospital Acquired Urinary Tract Infection Sales Forecast by Type (2018-2023)
12.3.2 Global Hospital Acquired Urinary Tract Infection Market Share Forecast by Type (2018-2023)
12.4 Hospital Acquired Urinary Tract Infection Market Forecast by Application (2018-2023)
12.4.1 Global Hospital Acquired Urinary Tract Infection Sales Forecast by Application (2018-2023)
12.4.2 Global Hospital Acquired Urinary Tract Infection Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Hospital Acquired Urinary Tract Infection Picture
Table Product Specifications of Hospital Acquired Urinary Tract Infection
Figure Global Sales Market Share of Hospi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
